GE HealthCare Technologies Inc. (FRA:L0T)

Germany · Delayed Price · Currency is EUR

67.18

+0.35 (0.52%)

Last updated: Jan 28, 2026, 10:29 AM CET

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Product Revenue	13.38B	13.08B
Service Revenue	6.87B	6.60B
Revenue (Other)	-1.00M	-
Revenue (Total)	20.25B	19.67B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Imaging Revenue (Post-Q2 2024)	9.09B	8.86B
Advanced Visualization Solutions (AVS) Revenue	5.27B	5.13B
Patient Care Solutions (PCS) Revenue	3.09B	3.13B
Pharmaceutical Diagnostics (PDx) Revenue	2.76B	2.51B
Other Revenue	47.00M	52.00M
Revenue (Total)	20.25B	19.67B

Revenue Breakdown 3

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Patient Care Solutions (PCS) Revenue	3.09B	3.13B
Pharmaceutical Diagnostics (PDx) Revenue	2.76B	2.51B
Other Revenue	47.00M	52.00M
Revenue (Total)	20.25B	19.67B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
USCAN Revenue	9.33B	8.98B
EMEA Revenue	5.24B	5.05B
China Revenue	2.32B	2.36B
Rest of World Revenue	3.36B	3.28B
Revenue (Other)	-3.00M	-
Revenue (Total)	20.25B	19.67B

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Imaging EBIT (Post-Q2 2024)	929.00M	962.00M
Advanced Visualization Solutions (AVS) EBIT	1.17B	1.12B
Patient Care Solutions (PCS) Segment EBIT	241.00M	347.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT	850.00M	783.00M
Other Segment EBIT	6.00M	2.00M
Operating Income (Other)	-462.00M	-587.00M
Operating Income (Total)	2.74B	2.63B

EBIT 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Patient Care Solutions (PCS) Segment EBIT	241.00M	347.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT	850.00M	783.00M
Other Segment EBIT	6.00M	2.00M
Operating Income (Total)	2.74B	2.63B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Products Remaining Performance Obligations (RPO)	4.90B	4.76B
Services Remaining Performance Obligations (RPO)	10.20B	9.74B
Total Remaining Performance Obligations (RPO)	15.10B	14.49B

Updated Sep 30, 2025. Data Source: Fiscal.ai.